Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: Observational study from the Florence district

Gut

Volumn 59, Issue 11, 2010, Pages 1511-1515

  Grazzini, Grazia ^a   Ventura, Leonardo ^b   Zappa, Marco ^b   Ciatto, Stefano ^a   Confortini, Massimo ^b   Rapi, Stefano ^c   Rubeca, Tiziana ^b   Visioli, Carmen Beatriz ^b   Halloran, Stephen P ^d  

^a ISPO Cancer Prevention and Research Institute   (Italy)

^b ISPO Cancer Prevention and Research Institute   (Italy)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

^d UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; AUTUMN; CANCER MORTALITY; CANCER SCREENING; COLORECTAL ADENOMA; COLORECTAL CANCER; ENVIRONMENTAL TEMPERATURE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMMUNOCHEMISTRY; ITALY; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OCCULT BLOOD; PRIORITY JOURNAL; SCREENING TEST; SEASONAL VARIATION; SPRING; SUMMER; WINTER; ANALYTICAL EQUIPMENT; COLORECTAL TUMOR; LABORATORY DIAGNOSIS; MASS SCREENING; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; ORGANIZATION AND MANAGEMENT; SEASON; STANDARD; TEMPERATURE;

AGED; COLORECTAL NEOPLASMS; FEMALE; HEMOGLOBINS; HUMANS; ITALY; LATEX FIXATION TESTS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; REAGENT KITS, DIAGNOSTIC; SEASONS; SPECIMEN HANDLING; STATISTICS, NONPARAMETRIC; TEMPERATURE;

EID: 78149246577     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2009.200873     Document Type: Article

References (24)

1. Hewitson P, Glasziou P, Irwig L, et al. Screening for colorectal cancer using the faecal occult blood test. Hemoccult Cochrane Database Syst Rev 2007;(1):CD001216.
2. Young GP, St John DJ, Winawer SJ, et al. Choice of fecal occult blood test for screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol 2002;97:2499-507.
3. Vilkin A, Rozen P, Levi Z, et al. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol 2005;100:2519-25.
4. Morikawa T, Kato J, Yamaji Y, et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005;129:422-8.
5. Guittet L, Bouvier V, Mariotte N, et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 2007;56:210-14.
6. van Rossum LG, van Rijn AF, Laheij RJ, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82-90.
7. Levi Z, Rozen P, Hazazi R, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007;146:244-55.
8. Zorzi M, Falcini F, Fedato C, et al. Screening for colorectal cancer in Italy: 2006 survey. Epidemiol Prev 2008;32(2 Suppl 1):55-68.
9. Castiglione G, Grazzini G, Miccinesi G, et al. Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood. J Med Screen 2002;9:99-103. (Pubitemid 35205230)
10. van Rossum LG, van Rijn AF, Laheij RJ, et al. Cutoff value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme. Br J Cancer 2009; 101:1274-81.
11. Guittet L, Bouvier V, Mariotte N, et al. Performance of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples. Int J Cancer 2009;125:1127-33.
12. Grazzini G, Visioli CB, Zorzi M, et al. Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? Br J Cancer 2009;100:259-65.
13. Hol L, Wilschut JA, van Ballegooijen M, et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer 2009;100:1103-10.
14. Launoy GD, Bertrand HJ, Berchi C, et al. Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population. Int J Cancer 2005;115:493-6. (Pubitemid 40663756)
15. Young GP, Sinatra MA, St John DJ. Influence of delay in stool sampling on fecal occult blood test sensitivity. Clin Chem 1996;42:1107-8.
16. Faure H, Exbrayat C, Winckel P, et al. Moisture content of Hemoccult slides influences test sensitivity. Eur J Gastroenterol Hepatol 2003;15:1111-14. (Pubitemid 37267227)
17. van Rossum LG, van Rijn AF, van Oijen MG, et al. False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening. Int J Cancer 2009;125:746-50.
18. Seniori Costantini A, Martini A, Puliti D, et al. Colorectal cancer mortality in two areas of Tuscany with different screening exposures. JNCI 2008;100: 1818-21.
19. Grazzini G, Castiglione C, Ciabattoni C, et al. Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. Eur J Cancer Prev 2004;13:19-26.
20. Halloran SP. Bowel cancer screening. Surgery 2009;27:397-400.
21. Ciatto S, Martinelli F, Castiglione G, et al. Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme. Br J Cancer 2007;96:218-21.
22. Anon. Screening retest fact sheet - National Bowel Cancer Screening Program. http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/ Content/bwretest (accessed 9 Oct 2009).
23. Fraser CG, Mathew CM, Ashley N, et al. Evaluation of a card collection-based faecal immunochemical test in screening for colorectal cancer using a two-tier reflex approach. Gut 2007;56:1415-18.
24. Levin B, Lieberman DA, McFarland B, et al. American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008;134:1570-95. (Pubitemid 351830302)